Tag: Johnson & Johnson
Johnson & Johnson discontinues selling talc-based baby powder in US
J&J faces more than 14,000 cases accusing Johnson & Johnson’s talc-containing products of causing ovarian cancer or mesothelioma, a rare form of cancer caused by asbestos exposure.
Johnson & Johnson settles with Ohio prior to opioid trial
Yesterday Johnson & Johnson settled two Ohio county claims prior to trial and will be paying $20.4 million. The company was accused...
“This ruling is huge”: Johnson & Johnson ordered to pay $572...
In a landmark ruling, an Oklahoma judge has ordered Johnson & Johnson to pay $572 million for contributing to the state’s opioid...
Landmark victory: Johnson & Johnson forced to pay $572 million for...
"The opioid crisis is an imminent danger and menace to Oklahomans."
Pharmaceutical hulk Johnson & Johnson keeps up lobbying efforts as lawsuits...
Amid an onslaught of lawsuits, Johnson & Johnson has kept pace with its historically hefty lobbying efforts as it wrestles to maintain influence in the halls of Congress.
Johnson & Johnson ordered to pay $25M in baby powder cancer...
According to Judge Manuel Mendez, who is presiding over the trial, Johnson & Johnson placed “corporate profits and reputation over the health and safety of consumers.”
Tell Johnson & Johnson to take responsibility for asbestos in their...
Johnson & Johnson must be held accountable for their failure to disclose that asbestos was found in their products.
POPULAR
Shutdown deal buries federal food safety rules amid rising outbreaks
A funding bill to avert a government shutdown includes industry backed provisions that halt key FDA protections even as foodborne illnesses surge across the United States.
Epstein’s intelligence ties come into focus as Congress moves toward releasing government files
A growing body of evidence details Jeffrey Epstein’s extensive work with Israeli intelligence while lawmakers push to force public access to government records that have remained hidden for years.
Human gene editing and the CRISPR revolution
CRISPR-based technology is advancing rapidly, driving international competition. Its promise to transform medicine is colliding with political and social realities, even as applications expand.
Countries agree to phase out mercury-based dental amalgams in tooth fillings by 2034
Signatories said the move will mark "a historic milestone in reducing mercury pollution" at a conference in Geneva.
Under Trump, rising costs are hitting families with $700 more per month
New Joint Economic Committee report shows inflation accelerating as White House withholds key CPI data.